Will You Be Attending Experimental Biology 2014?
April 17, 2014
The good folks at the American Society for Pharmacology and Experimental Therapeutics have seen fit to invite me to serve as an official blogger for the Experimental Biology 2014 meeting to be held in San Diego, CA, April 26-30. I will be joined in this effort by @katiesci who blogs at http://sicknessisfascinating.blogspot.com.
I would like to invite you, Dear Readers, to send me your presentation details, should you be attending this year. You can drop a note in the comments to this thread or send me an email (drugmnky at the google mail). I will try to stop by if it fits in my schedule and maybe blog it if I can understand what you do.
There may also be a meet up or two which revolves around either this community at the blog or my Twitter Tweeps. So stay in touch about that. If you are interested in such a thing and leave a comment, this may help to stimulate someone (say, me) to get off their behind and organize something.
Looking forward to seeing some of your science and to meeting some of you.
DrugMonkey 
April 18, 2014 at 10:54 am
I’m on a panel talking about science policy careers on Sunday from 2:45-6 pm (iirc): http://experimentalbiology.org/2014/Program-Information/Society-Programs/ASBMB.aspx
I would be very interested in a tweetup especially if it’s somewhere with beer. Saturday is better for me than Sunday but my flight on Sunday is ~10 pm so I could still make it on Sunday even after my talk.
Of course, that presupposes people want to meet me 😉
LikeLike
April 22, 2014 at 4:58 am
The Arkansas Mafia will be presenting a symposium on synthetic cannabinoids on Wednesday from 9:30 AM – 12:00 PM. We’ll be competing with the Ray Fuller symposium, which is lame. Anyway, here’s the details:
Scientists versus street chemists: The toxicity of designer marijuana
San Diego Convention Center, Room 3
9:30 AM – 12:00 PM
Supported by funding from Cayman Chemical Company
Sponsored by the Divisions for Toxicology; Behavioral Pharmacology; Integrative Systems, Translational and Clinical Pharmacology; and Neuropharmacology
Chairs: Laura P. James, Arkansas Children’s Hosp. and Jeffery H. Moran, Univ. of Arkansas for Med. Sciences
An analytical chemist’s approach to public health problems
Jeffery H. Moran, Arkansas Dept. of Health
Atypical in vitro pharmacodynamic and metabolic characteristics of K2 synthetic cannabinoids: Keys to toxicity?
Paul L. Prather, Univ. of Arkansas for Med. Sciences
Pharmacodynamic and pharmacokinetic factors impacting the in vivo pharmacology and toxicology of K2 synthetic marijuana
William E. Fantegrossi, Univ. of Arkansas for Med. Sciences
Clinical and unexplained idiosyncratic toxicity of K2 exposure
Genevieve L. Buser, Oregon Hlth. Authority
Junior Speaker: Functional Consequences of Synthetic Cannabinoid Metabolites and CYP2C9 Polymorphisms
Catherine Allen, Univ. of Central Arkansas
LikeLike
April 22, 2014 at 8:05 am
Thanks for the head’s up, Bill. We love discussing the fake weed around these parts.
LikeLike
April 22, 2014 at 6:11 pm
Thanks for the shoutout! I’ve lined up some cool research to blog about.
I’d be interested in a tweet up . I don’t get in until Sunday morning.
I’ll likely tweet about my poster location as a #disappearingtweet the day of. I’ll tag you in it in case you want to stop by.
LikeLike